Cancer Diagnosis News and Research

RSS

Cedars-Sinai surgeons detect and remove 25-pound cancerous ovarian tumor

Maria Robles Garcia was sure her uncomfortable abdominal symptoms weren't caused by irritable bowel syndrome or from being overweight, no matter that her local doctors repeatedly told her that was the case.

13 Nov 2019

Genetic diversity impacts efficacy of cancer immunotherapy

The constant battle against infectious pathogens has had a decisive influence on the human immune system over the course of our evolution.

8 Nov 2019

NLCRT expands portal of resources to help Americans fight lung cancer

The National Lung Cancer Roundtable has expanded its portal of resources to help Americans fight lung cancer. The updated Resource Center includes new videos, infographics, research, and more.

6 Nov 2019

Cancer risk reduces to half with over 20% weight loss in post- bariatric surgery patients

Patients with severe obesity who had bariatric or weight-loss surgery and lost more than 20% of their total weight were 50% less likely to develop cancer compared to patients who did not have as much weight loss after surgery, according to a new study presented today by Oregon Health & Science University researchers at the 36th American Society for Metabolic and Bariatric Surgery Annual Meeting at ObesityWeek 2019.

5 Nov 2019

Family caregivers should be entitled to six months paid time off work, say experts

People who look after loved ones nearing the end of their lives should be entitled to up to six months paid time off work and safeguards for their job so they can return to work, according to academics from the University of Sheffield's School of Nursing and Midwifery.

4 Nov 2019

Facts about lung cancer and ways to reduce your risk

Lung cancer is the second most common cancer in both men and women in the United States. According to the American Cancer Society, about 13% of all new cancers are lung cancers. There will be an estimated 228,000 new cases of lung cancer this year, with more than 142,000 deaths. Moreover, the 5-year survival rate is less than 20%.

4 Nov 2019

Two-hormone combo test predicts prostate cancer risk

New research presented at the NCRI Cancer Conference, 2019, shows that free testosterone and insulin-like growth factor-1 (IGF-I), when present at high levels in combination, show a higher risk of prostate cancer in men. This finding is important since both these factors can be counteracted, to possibly reduce the risk.

3 Nov 2019

UCLA prostate cancer program receives $8.7 million grant from NCI

The prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center and UCLA Health has been awarded an $8.7 million Specialized Program of Research Excellence, or SPORE, grant from the National Cancer Institute.

31 Oct 2019

Skin cancer diagnosis using AI technology could be as accurate as clinical specialist

New clinical data published in Journal of American Medical Association demonstrates first-in-class AI algorithm is able to diagnose skin cancer with a high-level of accuracy comparable to a clinical specialist.

29 Oct 2019

New diagnostic technique enables grading of tumor consistency using MRI

Researchers from Charité - Universitätsmedizin Berlin have developed a new diagnostic technique which enables the grading of tumor consistency using magnetic resonance imaging (MRI). The researchers used an imaging technique known as tomoelastography to visualize the mechanical properties of liver tumors.

28 Oct 2019

Coloring and open-studio art therapy benefits stressed caregivers of cancer patients, study shows

A cancer diagnosis is incredibly stressful for the person receiving the diagnosis. But those caring for the patient, both informally and formally, also experience stress, which can affect their own health and the patient's outcome.

21 Oct 2019

Transatlantic research alliance aims to develop radical new strategies for early cancer detection

Developing radical new strategies and technologies to detect cancer at its earliest stage is the bold ambition of a new transatlantic research alliance, announced today (Monday) by Cancer Research UK and partners.

18 Oct 2019

Researchers outline new exercise recommendations for people living with and beyond cancer

It's well known that exercise is good for preventing and treating many forms of heart disease, but less commonly known are the benefits of physical activity for people living with and beyond cancer.

16 Oct 2019

New guidance recommends systematic use of 'exercise prescription' for cancer patients

A global panel of exercise oncology experts today published new guidance recommending the systematic use of an “exercise prescription” to help cancer patients cope with treatment side effects and lower the risk of developing certain cancers.

15 Oct 2019

Overweight before age 40 linked to increased cancer risk

In an international study, lead by the University of Bergen in Norway, the researchers wanted to find out how adult overweight (BMI over 25) and obesity (BMI over 30) increase the risk of different types of cancer.

11 Oct 2019

New blood test could help hasten the diagnosis of brain tumors

A blood test which could help to accelerate the diagnosis of brain cancer has been developed in research led at the University of Strathclyde.

9 Oct 2019

Osaka University Hospital begins clinical research for prostate cancer diagnosis using PET imaging

Osaka University Hospital began Japan's first clinical research for diagnosis of prostate cancer using PET (positron emission tomography) scan results in September 2019.

7 Oct 2019

Women under 40 often choose aggressive surgery out of fear of second breast cancer

Yes, it's not common. Breast cancer among women under 40 is rare. No matter the age, a cancer diagnosis causes anxiety and fear. In addition, women in their 20s and 30s face some unique challenges and daunting decisions. Deciding what type of surgery to have is one of them.

3 Oct 2019

Multi-gene testing at point of diagnosis can save all women with breast cancer

A lifetime model evaluating the financial, health and social impact of multi-gene testing (BRCA1/2/PALB2) at diagnosis for all breast cancer patients was found to be extremely cost effective for both UK and US health systems.